PDPs offer a model to address the need for new or improved products to combat diseases of the poor for which prevention or treatment is lacking or inadequate or that have become resistant to current treatments.  The PDP model emerged to fill gaps which other organizations could not or would not meet.

The success of each PDP will depend on its scope, the maturity of science, the ability to secure funding for its mission and the ability to work with other players in a way that ensure that the right product is developed and that it gets to those who need it most.”

Source:  Sander & Widdus in Combating Diseases Associated with Poverty: Financing Strategies for Product Development and the Potential Role of Public-Private Partnerships.  2004.


click here for more details on the characteristics of PDPs


Stand alone single or multi disease PDPs with more than one funder

     •     Aeras Global TB Vaccine Foundation (Aeras)

     •     Drugs for Neglected Diseases initiative (DNDi)

     •     European Vaccine Initiative (EVI)

     •     Foundation for Innovative New Diagnostics (FIND)

     •     Global Alliance for TB Drug Development (TB Alliance)

     •     International AIDS Vaccine Initiative (IAVI)

     •     International Partnership for Microbicides (IPM)

     •     Innovative Vector Control Consortium (IVCC)

     •     Medicines for Malaria Venture (MMV)

     •     TuBerculosis Vaccine Initiative (TBVI)

PDP like entities hosted by PATH

     •     Malaria Vaccine Initiative (MVI)

     •     Meningitis Vaccine Project (MVP)

     •     Path Drug Development Program

     •     Vaccine Development Program

     •     Enteric Vaccine Development

     •     Pandemic Influenza Project

     •     Pneumococcal Vaccine Project

     •     Rotavirus Vaccine Development